Timeplast, Inc. has filed an updated offering statement with the SEC, aiming to raise up to $30.78 million by selling shares of common stock. This move is significant for the company as it seeks to expand its operations within the plastics industry, specifically in the realm of synthetic resins and elastomers.
The offering includes a maximum of 6,088,457 shares, consisting of 5,071,795 shares to be issued for cash consideration, 906,791 shares to be issued as bonus shares, and 109,871 shares being sold by existing stockholders. The price per share is set at $4.93, with a 3% processing fee applicable to investors.
Background
Timeplast, Inc. is a company incorporated in Delaware in 2013, operating within the SIC category of 2821, which encompasses Plastic Materials, Synthetic Resins & Nonvulcan Elastomers. The company has recently filed several forms with the SEC, including multiple amendments to its offering statement under Regulation A, indicating an active approach to capital raising.
What the Filing Says
The latest filing, dated November 3, 2026, outlines the terms of the offering, stating, "We are offering, on a 'best efforts' basis, a maximum of 6,088,457 shares of Common Stock..." The filing also specifies that eligible investors may receive bonus shares regardless of whether their purchased shares are offered by the company or by selling stockholders.
Impact
This offering may affect various stakeholders, including potential investors looking to participate in Timeplast's growth, as well as existing stockholders who may see dilution of their shares due to the issuance of new shares. The involvement of DealMaker Securities, LLC as the broker-dealer also highlights the structured approach the company is taking to ensure compliance and effective distribution of the offering.
What's Next
The filing does not specify what happens next, but it indicates that the company may proceed with the offering once it receives qualification from the SEC. Investors interested in participating will need to meet the minimum investment requirement of 200 shares, or approximately $986, plus the processing fee.
Read Next
Polomar Health Services Announces Non-Reliance on Financials
Rocky Brands reports Q3 results with slight revenue decline
Kadant Inc. Reports Strong Q3 2026 Financial Results
Nextchip Inc. Files Regulation A Offering for $260,000
Lindblad Expeditions Reports Third-Quarter Results
Pulmonx Corp Reports Q3 Results Amidst Industry Challenges










